10 Best Healthcare Equipment Stocks For 2015

The combination of US and political risks has eroded much of the positive sentiment seen after the Fed’s decision to delaying tapering two weeks ago. However –

1. Current expectations now believe that Italy is less of a problem then the US – As many as 20 senators from former Italian PM Berlusconi’s PDL party are rumored to be ready to form a breakaway party in order to hold the Italian government together.

2. Italian Pro-coalition news is strongly EUR positive. Dollar selling may continue into today’s 11am fix with month and quarter end rebalancing a focus.

3. Euro equity markets have steadied after an early sharp selloff – investors accustomed to Italian political shenanigans decline to make a "wholesale sprint to the exit doors."

4. With the US heading towards a partial government shutdown continues to squeeze the greenback – there are still no concrete signs of a budget funding deal before tonight’s midnight shu tdown deadline.

10 Best Healthcare Equipment Stocks For 2015: Hanwha SolarOne Co. Ltd.(HSOL)

Hanwha Solarone Co., Ltd., an investment holding company, engages in the manufacture and sale of silicon ingots, silicon wafers, and PV cells and modules. The company also offers mono crystalline and multi crystalline silicon cells; and provides PV module processing services. It sells its products to solar power system integrators and distributors primarily in Germany, Italy, Australia, the United States, the Czech Republic, Spain, and China. The company was formerly known as Solarfun Power Holdings Co., Ltd. and changed its name to Hanwha SolarOne Co., Ltd. in December 2010. Hanwha Solarone Co., Ltd. was founded in 2004 and is based in Qidong, the People?s Republic of China.

Advisors’ Opinion:

  • [By Paul Ausick]

    Big Earnings Movers: Hanwha SolarOne Co. (NASDAQ: HSOL) is down 13.9% at $4.36. D.R. Horton Inc. (NYSE: DHI) is up 4.7% at $18.91 on good earnings boosted by land sales.

  • [By Travis Hoium]

    News and notes
    Hanwha SolarOne (NASDAQ: HSOL  ) announced another $100 million in financing this week, this time a term loan from the Export-Import Bank of Korea.  

  • [By Travis Hoium]

    What: Solar stocks are shooting higher again today as the strong run in 2013 continues. LDK Solar (NYSE: LDK  ) , Canadian Solar (NASDAQ: CSIQ  ) , Yingli Green Energy (NYSE: YGE  ) , Hanwha SolarOne (NASDAQ: HSOL  ) , and JinkoSolar (NYSE: JKS  ) led the way, gaining between 10% and 22% today.

  • [By Sean Williams]

    Lights out, China
    China may have its fair share of struggles — which has caused its strong economy to back off its 30-year average growth rate of 10% — but when push comes to shove, plenty of investors are still paying close attention to multinational companies making investments in China. However, if there were one sector with a gigantic “beware” stamp attached to it, it would be Chinese solar panel producers like Hanwha SolarOne (NASDAQ: HSOL  ) .

10 Best Healthcare Equipment Stocks For 2015: In-Touch Survey Systems Ltd (INX)

In-Touch Survey Systems Ltd. is engaged in designing, developing and implementing of data capture technologies and services for business to consumer (B2C) companies. The Company does business as Service Intelligence, In-Touch Insight Systems and IMS division. In-Touch Insight Systems (EDC) develops managed mobile software technology and services for business to consumer (B2C), business to business (B2B), governments and regulators. In-Touch has developed a software platform, In- Touch Apps that provides for the development of data collection programs, mobile forms creations and real-time online reporting for its customers. Service Intelligence (MDC) provides onsite audit and Mystery Shopping services to B2C companies in Canada and the United States. The IMS division, which provides enterprise software engineering services to the Canadian Federal Government. Advisors’ Opinion:

  • [By Henry Lee]

    After hitting a fresh high of nearly 1900 on April 4, the S&P 500 (INX) closed last Friday at 1816 – a 4.3% drop in just one week. We’ve seen a bit of a rebound, but the worst week in two years rattled investors. Nasdaq (IXIC) got close to a 10% drop from its March high, which would make it an official “correction” – a nice word that masks the pain many investors are feeling.

10 Best Healthcare Equipment Stocks For 2015: Concho Resources Inc. (CXO)

Concho Resources Inc., an independent oil and natural gas company, engages in the acquisition, development, and exploration of producing oil and natural gas properties in the United States. Its operations are focused in the Permian Basin of Southeast New Mexico and West Texas. The company also has acreage positions in the Bakken/Three Forks play in North Dakota. As of December 31, 2010, Concho Resources had estimated proved reserves of 323.5 million barrel of oil equivalent. The company is headquartered in Midland, Texas.

Advisors’ Opinion:

  • [By Laura Brodbeck]

    Monday

    Earnings Releases Expected:  McKesson (NYSE: MCK), Concho Resources (NYSE: CXO), Diamondrock Hospitality (NYSE: DRH) Economic Releases Expected:  US Federal budget balance, Indian industrial production

    Tuesday

  • [By Jim Jubak]

    Having done about all it could to increase US crude exports, by granting export licenses to Canada (permitted under the current system), I think the Obama administration is likely to move to grant new export licenses to countries other than Canada in 2014. That policy change would turn US oil producers into a rare bright spot in an energy sector that is looking at stable or falling global oil prices in 2014. Stocks I’d take a look at are Pioneer Natural Resources (PXD), Concho Resources (CXO) and Targa Resources Partners (NGLS). Pioneer Natural Resources is a member of my Jubak Picks 50 long-term portfolio. Targa Resources Partners is a member of my Jubak’s Picks 12-18 month portfolio

  • [By Robert Rapier]

    There are numerous drillers making major investments in the Permian Basin. The list is long, but it includes Occidental Petroleum (NYSE: OXY), Chevron (NYSE: CVX), Devon Energy (NYSE: DVN), Pioneer Natural Resources (NYSE: PXD), Concho Resources (NYSE: CXO), ConocoPhillips (NYSE: COP) and Apache (NYSE: APA).

  • [By Russ Krull]

    Concho Resources (NYSE: CXO  ) reopened an issue from last August and sold $850 million of 10-year, 5.5% paper. Concho got a better deal on this round, selling the paper at 103.75% of par, compared with even par last August. About $320 million of the new money is funding a tender offer for some higher-rate 2017 paper. The rest of the money goes toward paying down a credit facility and for general corporate purposes.

10 Best Healthcare Equipment Stocks For 2015: Seven & i Holdings Co Ltd (SVNDY)

Seven & i Holdings Co., Ltd. is a Japan-based holding company. The Company operates in six business segments. The Convenience Store segment operates convenience stores under the name 7-Eleven through direct operation and franchising. The Super Store segment operates general supermarkets, food supermarkets and specialty stores. The Department Store segment operates department stores with a focus on Seibu. The Food Service segment is engaged in the restaurant business, the contract food business and the fast food business. The Financial-related segment is engaged in the banking service, credit card and electronic money services. The Others segment is engaged in the information technology (IT) business. Advisors’ Opinion:

  • [By Jim Jubak]

    If you’re a trader, you try to catch these ups and downs. If you’re a longer term trader, you sort of go with Japanese equities. The one that I’ve got in Jubak’s Picks is Toyota Motor, (TM), which trades in New York as an ADR. You can also go with something like Torre Industries (TRYIF), which trades as an ADR in New York as well as on the Tokyo exchange. They’re the world’s largest maker of carbon fiber, good play on exports to the aircraft and car industries. Or you can do something like Seven & I (SVNDY), the Japanese company that owns 7-Elevens around the world. So, those would be my ways to play a weak yen if you want to use Japanese equities for the week and the year ahead.

10 Best Healthcare Equipment Stocks For 2015: National Western Life Insurance Company(NWLI)

National Western Life Insurance Company provides life insurance products for the savings and protection needs of policyholders and annuity contracts for the asset accumulation and retirement needs of contract holders. Its life products include universal life insurance and interest-sensitive whole life, as well as traditional products, such as term insurance coverage; and annuity products comprise flexible premium and single premium deferred annuities, fixed indexed annuities, and single premium immediate annuities. The company markets and distributes its insurance products primarily through independent national marketing organizations to residents of various countries in central and South America, the Caribbean, the Pacific Rim, eastern Europe, and Asia. It also engages in small real estate, nursing home, and other investment operations. The company was founded in 1956 and is based in Austin, Texas.

Advisors’ Opinion:

  • [By David Merkel]

    The two stocks in question are Stancorp Financial (SFG) and National Western Life Insurance (NWLI). The short cases for both are based on a naive view of how insurance companies work.

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, life insurance company National Western Life Insurance Company (NASDAQ: NWLI  ) has earned a coveted five-star ranking.

10 Best Healthcare Equipment Stocks For 2015: ImmunoCellular Therapeutics Ltd (IMUC)

ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company’s products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient’s immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).

The Company in addit ion to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients’ tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and s erum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.

The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.

Advisors’ Opinion:

  • [By Monica Gerson]

    ImmunoCellular Therapeutics (NYSE: IMUC) dropped 11.05% to $1.3699. ImmunoCellular’s trailing-twelve-month ROE is -59.80%.

    Posted-In: market losersNews Movers & Shakers Intraday Update Markets

  • [By Wallace Witkowski]

    Shares of ImmunoCellular (IMUC)  jumped after the drug developer said data on a mid-stage brain cancer drug study were looking encouraging.

10 Best Healthcare Equipment Stocks For 2015: Kyocera Corp (KYOCF)

KYOCERA CORPORATION mainly develops products for the information and communications market. The Fine Ceramic segment offers semiconductor and liquid crystal manufacturing equipment parts, and information communication parts. The Semiconductor Parts segment offers ceramic and optical communication packages. The Fine Ceramic Applied Product Related segment offers residential, industrial photovoltaic generations. The Electronic Device segment offers ceramic capacitors, tantalum capacitors. The Communication Device segment provides personal handy phone systems (PHSs). The Information Equipment segment offers monochromes and combined machine. The Others segment provides information communication services. On April 1, 2013, it transferred the liquid crystal display related business to KYOCERA Display Corporation. On October 1, 2013, it acquired a 55% stake in NEC TOPPAN CIRCUIT SOLUTIONS, INC. from Toppan Printing Co Ltd, and acquired another 45% stake from NEC Corporation. Advisors’ Opinion:

  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) — Japanese stocks weakened in early Thursday trading as the yen rose and Wall Street ended mixed, with the Nikkei Stock Average (JP:NIK) falling 1.2% to 15,929.74 after a 1.9% advance a day earlier. With the yen (USDJPY) slightly firmer than in the previous session, some investors sold currency-sensitive exporters, with Fanuc Corp. (JP:6954) (FANUF) down 2%, Kyocera Corp. (JP:6971) (KYOCF) off 1.9%, and Fujitsu Ltd. (JP:6702) (FJTSY) losing 2.3%. News that China would lift a ban on some sales of videogame consoles had sent shares of Nintendo Co. (JP:7974) (NTDOF) shooting 11% higher on Wednesday, but apparent profit-taking sent the stock down 4.2% in early Thursday action. Shares of rival Sony Corp. (JP:6758) (SNE) , however, followed with a 4% rise, also possibly buoyed by a Nikkei Asian Review report that it was planning a “smartphone offensive” in the U.S. and China. Canon Inc. (JP:7751) (CAJ) fell 2% on a separate Nikkei report that the company’s 2013 operating profit would miss forecasts. Toshiba Corp. (JP:6502) (TOSYY)

  • [By Daniel Inman]

    Shares of Japanese real-estate companies managed to move higher in Tokyo, with Mitsui Fudosan (JP:8801)   (MTSFF)  up 1.6%, and Mitsubishi Estate Co. (JP:8802)   (MITEF)  up 1.9%. Local exporters, however, failed to lead the market lower: Honda Motor Co. (JP:7267)   (HMC)  lost 0.8%, and Kyocera Corp. (JP:6971)   (KYOCF)  fell 0.6%

10 Best Healthcare Equipment Stocks For 2015: Cinemark Holdings Inc(CNK)

Cinemark Holdings, Inc. and its subsidiaries engage in the motion picture exhibition business. As of June 30, 2011, it operated 436 theatres with 4,983 screens in 39 states of the United States, as well as in Brazil, Mexico, and 11 other Latin American countries. The company is headquartered in Plano, Texas.

Advisors’ Opinion:

  • [By Sue Chang]

    Cinemark Holdings Inc. (CNK) : The movie theater company is well positioned to capitalize on the film’s popularity with movie goers with operations both in the U.S. and Latin America. Shares of Cinemark are up 26% so far this year.

  • [By Rich Smith]

    As movie-theater operator Cinemark (NYSE: CNK  ) exits the Mexican market, another “gringo” is expanding to fill the gap — from even farther north of the border.

  • [By John Udovich]

    The shares of small cap IMAX Corporation (NYSE: IMAX) have slipped more than 10% this week on growth concerns – meaning it might be a good idea to take a closer look at the stock plus its performance verses other cinema stocks like Carmike Cinemas, Inc (NASDAQ: CKEC), Cinemark Holdings, Inc (NYSE: CNK) and Regal Entertainment Group (NYSE: RGC) along with the PowerShares Dynamic Leisure & Entertainment ETF (NYSEARCA: PEJ).

10 Best Healthcare Equipment Stocks For 2015: Worthington Industries Inc.(WOR)

Worthington Industries, Inc. operates as a diversified metals processing company focusing on steel processing and manufactured metal products in the United States, Canada, and Europe. It processes flat-rolled steel and stainless steel for the automotive, construction, lawn and garden, hardware, furniture, office equipment, electrical control, tubing, leisure and recreation, appliance, agricultural, HVAC, container, and aerospace markets. The company also produces low-pressure liquefied petroleum gas and refrigerant gas cylinders; high-pressure and industrial/specialty gas cylinders; seamless steel high pressure cylinders for compressed natural gas storage in motor vehicles; aluminum-lined, composite-wrapped high-pressure cylinders; airbrake tanks; and consumer products. In addition, it produces recovery tanks for refrigerant gases; air reservoirs for truck and trailer original equipment manufacturers; and Balloon Time helium kits. Further, the company designs and manufactu res reusable custom platforms, racks, and pallets made of steel for supporting, protecting, and handling products throughout the shipping process; provides framing systems and stairs for mid-rise buildings, and current and past model automotive service stampings; designs, builds, and supplies light gauge steel framed commercial structures and multi-family housing units; supplies and constructs metal framing products for single family housing with a focus on military housing; and manufactures pre-engineered steel egress stair solutions. Worthington Industries was founded in 1955 and is headquartered in Columbus, Ohio.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Harsco have gained 4.7% to $26.43 today at 1:16 p.m., outpacing other construction & engineering companies. Dycom (DY) has advanced 0.5% to $30, KBR Inc. (KBR) has ticked up 0.1% to $33.03, Worthington Industries (WOR) has risen 2.8% to $38.85 and Tutor Perini (TPC) has rallied 3.6% to $22.46.

  • [By Yoshiaki Nohara]

    Orix Corp., which provides leasing and loans, jumped 9.2 percent in Tokyo. Mizuno (8022) Corp. surged 18 percent after the Japanese sportswear company more than doubled its net-income forecast. Singapore Airlines Ltd. dropped 4.6 percent after posting a wider operating loss. WorleyParsons (WOR) Ltd., Australia’s largest oil and gas engineering company, plunged 13 percent after forecasting weaker earnings.

10 Best Healthcare Equipment Stocks For 2015: TearLab Corporation(TEAR)

TearLab Corporation operates as an ophthalmic device company. It engages in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company?s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab disposable and the TearLab pen, as well as provides a quantitative reading for the operator. TearLab Corporation markets its system through a network of distributors in North America, Europe, and Asia. The company, formerly known as OccuLogix, Inc., was founded in 1996 and is headquart ered in San Diego, California.

Advisors’ Opinion:

  • [By Seth Jayson]

    TearLab (Nasdaq: TEAR  ) reported earnings on May 13. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), TearLab beat expectations on revenues and exceeded expectations on earnings per share.

  • [By Roberto Pedone]

    One potential earnings short-squeeze candidate is in-vitro diagnostic player TearLab (TEAR), which is set to release numbers on Tuesday after the market close. Wall Street analysts, on average, expect TearLab to report revenue of $3.51 million on a loss of 13 cents per share.

    This company has managed to top Wall Street estimates two times over the last four quarters, which is a bullish earnings trend. If TearLab can delve another beat, then shares could be setting up for a large move higher.

    The current short interest as a percentage of the float for TearLab is extremely high at 37.1%. That means that out of the 25.54 million shares in the tradable float, 8.59 million shares are sold short by the bears. This is a huge short interest on a stock with a very low tradable float. If the bulls get the earnings news they’re looking for, then shares of TEAR could easily explode higher post-earnings as the bears jump to cover some of their bets.

    From a technical perspective, TEAR is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares moving higher from its low of $5.26 to its recent high of $15.18 a share. During that uptrend, shares of TEAR have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of TEAR within range of triggering a major breakout trade post-earnings.

    If you’re bullish on TEAR, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $14.28 to its 52-week high at $15.18 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 942,598 shares. If that breakout hits, then TEAR will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside